HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors

NCT07296341 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced or Metastatic Pancreatic Cancer With

Interventions

DRUG: HRS-4642;Adebrelimab Injection; nab-paclitaxel; gemcitabine
DRUG: HRS-4642;nab-paclitaxel; gemcitabine

Sponsor

Shanghai Hengrui Pharmaceutical Co., Ltd.